drugset

drugset / Trial / NCT05405257

Oxytocin for Hypermobile Ehlers-Danlos Syndrome

NCT05405257 ↗

Phase 1/2 Terminated 2 enrolled Baylor College of Medicine

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this pilot study is to evaluate effect of IV oxytocin on chronic pain in patients with Hypermobile Ehlers Danlos syndrome.

Timeline

Start: 2022-05-13
Primary completion: 2025-03-11
Completion: 2025-03-11

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Oxytocin	Peptide	1 iu	Intravenous

Indications